EMs and Japan top GMO’s seven-year outlook
The S&P500 is expected to flatline, and China is “California on steroids”, says Edward Chancellor at GMO.
Edward Chancellor, Boston-based head of capital markets research and a member of the asset-allocation team at the $106 billion GMO, says the firm’s seven-year forecast has the S&P500 returning essentially zero returns on an annualised basis.
Sign In to Your Account
Access Exclusive AsianInvestor Content!
Please sign in to your subscription to unlock full access to our premium AI resources.
Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial—no registration fees required. Click the link to get started.
Note: This free trial is a one-time offer.
¬ Haymarket Media Limited. All rights reserved.